AAPL   366.37 (+0.62%)
MSFT   207.45 (+1.34%)
FB   234.07 (-1.47%)
NVDA   386.99 (+1.52%)
MU   50.22 (+1.05%)
GE   6.82 (+1.19%)
TSLA   1,209.24 (+8.00%)
T   30.30 (+1.30%)
GILD   76.69 (+0.82%)
DIS   112.89 (-0.12%)
AAPL   366.37 (+0.62%)
MSFT   207.45 (+1.34%)
FB   234.07 (-1.47%)
NVDA   386.99 (+1.52%)
MU   50.22 (+1.05%)
GE   6.82 (+1.19%)
TSLA   1,209.24 (+8.00%)
T   30.30 (+1.30%)
GILD   76.69 (+0.82%)
DIS   112.89 (-0.12%)
AAPL   366.37 (+0.62%)
MSFT   207.45 (+1.34%)
FB   234.07 (-1.47%)
NVDA   386.99 (+1.52%)
MU   50.22 (+1.05%)
GE   6.82 (+1.19%)
TSLA   1,209.24 (+8.00%)
T   30.30 (+1.30%)
GILD   76.69 (+0.82%)
DIS   112.89 (-0.12%)
AAPL   366.37 (+0.62%)
MSFT   207.45 (+1.34%)
FB   234.07 (-1.47%)
NVDA   386.99 (+1.52%)
MU   50.22 (+1.05%)
GE   6.82 (+1.19%)
TSLA   1,209.24 (+8.00%)
T   30.30 (+1.30%)
GILD   76.69 (+0.82%)
DIS   112.89 (-0.12%)
Log in

CVE:NUNeutriSci International Stock Price, Forecast & News

C$0.06
+0.01 (+8.33 %)
(As of 07/2/2020 03:15 PM ET)
Add
Compare
Today's Range
C$0.07
Now: C$0.07
C$0.08
50-Day Range
C$0.06
MA: C$0.06
C$0.07
52-Week Range
C$0.02
Now: C$0.07
C$0.09
Volume262,953 shs
Average Volume275,328 shs
Market CapitalizationC$9.37 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
NeutriSci International Inc. develops and markets nutraceutical products in Canada and internationally. It offers Neuenergy, a chewable tablet designed to deliver enhanced focus and mental clarity; nu.thc and nu.cbd sugar-free chewable cannabinoid tablets that offer a metered dose of THC/CBD; and BluScience line of products to support optimal health. The company markets its products through retail and online channels. NeutriSci International Inc. is headquartered in Calgary, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone403-264-6320

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$54,596.00
Cash FlowC$0.00 per share
Book ValueC$0.00 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$9.37 million
Next Earnings Date9/3/2020 (Estimated)
OptionableNot Optionable

Receive NU News and Ratings via Email

Sign-up to receive the latest news and ratings for NU and its competitors with MarketBeat's FREE daily newsletter.

NeutriSci International (CVE:NU) Frequently Asked Questions

How has NeutriSci International's stock been impacted by COVID-19 (Coronavirus)?

NeutriSci International's stock was trading at C$0.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NU shares have increased by 62.5% and is now trading at C$0.07. View which stocks have been most impacted by Coronavirus.

When is NeutriSci International's next earnings date?

NeutriSci International is scheduled to release its next quarterly earnings announcement on Thursday, September 3rd 2020. View our earnings forecast for NeutriSci International.

Has NeutriSci International been receiving favorable news coverage?

Headlines about NU stock have trended very negative on Thursday, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NeutriSci International earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about NeutriSci International.

Who are some of NeutriSci International's key competitors?

What other stocks do shareholders of NeutriSci International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NeutriSci International investors own include Aurora Cannabis (ACB), Emcor Group (EME), Incyte (INCY), Northwest Pipe (NWPX), UnitedHealth Group (UNH), Watsco (WSO), Zimmer Biomet (ZBH), 3i Infrastructure (3IN), Axos Financial (AX) and Actinium Pharmaceuticals (ATNM).

Who are NeutriSci International's key executives?

NeutriSci International's management team includes the following people:
  • Mr. Glen Rehman, CEO, Pres & Director
  • Mr. John Robert Chisholm, Chief Financial Officer (Age 57)
  • Mr. Thierry Sorhaitz, VP of Sales & Marketing

What is NeutriSci International's stock symbol?

NeutriSci International trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NU."

How do I buy shares of NeutriSci International?

Shares of NU and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is NeutriSci International's stock price today?

One share of NU stock can currently be purchased for approximately C$0.07.

How big of a company is NeutriSci International?

NeutriSci International has a market capitalization of C$9.37 million and generates C$54,596.00 in revenue each year.

What is NeutriSci International's official website?

The official website for NeutriSci International is www.neutrisci.com.

How can I contact NeutriSci International?

The company can be reached via phone at 403-264-6320.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.